Clinical trial Recruiting at 1 site Observational Ages 18 and up

Collecting blood and urine samples from bladder cancer patients

Official title: Bladder Bank (a Prospective Banking Study)

Run by Mayo Clinic · NCT06109857 · Data updated 2026-11-12

This study is collecting blood and urine samples from bladder cancer patients to see if these samples can help create better tests for early detection of the disease.

More Muscle-Invasive Bladder Carcinoma trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1500 (estimated)
SponsorMayo Clinic
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Rochester, Minnesota)
StatusRecruiting
StartedJuly 6, 2022
Main results expectedDecember 1, 2027
Study endsDecember 1, 2027
Registry record updatedOctober 14, 2026
Trial IDNCT06109857 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years who have undergone evaluation for hematuria.

Probably not a fit

Patients with known cancer outside of bladder carcinoma or those with recurrent muscle invasive bladder cancer may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish a biobank of blood and urine samples from patients diagnosed with bladder carcinoma. The primary objective is to support the development of non-invasive tests for the early detection of bladder cancer. Participants will undergo sample collection and have their medical records reviewed while enrolled in the study. This approach allows researchers to gather valuable biological materials that can aid in advancing diagnostic methods for bladder cancer.

Why it matters

Potential benefit: If successful, this study could lead to improved early detection methods for bladder cancer, potentially increasing survival rates.

How similar studies have gone: Other studies have successfully established biobanks for cancer research, indicating that this approach has potential for meaningful contributions to early detection methods.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \> 18 years
* Patient has undergone office-based evaluation for hematuria \[computed tomography (CT), ultrasound, cystoscopy\]

Exclusion Criteria:

* Patient has known cancer outside of the target cancer 5 years prior to current collection (not including basal cell or squamous cell skin cancers; if patient has not been seen or if information is not available, the patient is eligible)
* Patient has recurrent muscle invasive bladder cancer
* Patient has ever been previously diagnosed with UTUC (upper tract urothelial carcinoma) prior to bladder resection
* Patient has received chemotherapy class drugs for the treatment of non-target origin cancer in the 5 years prior to current collection
* Patient has had any prior radiation therapy to the target lesion prior to current collection
* Patient has had a biopsy to the target organ and/or lesion within 3 days before collection
* Patient has undergone cystectomy or cystoprostatectomy
* Patient has transurethral instrumentation (placement of urinary catheter) within 7 days prior to urine collection
* Patient has had a urinary tract infection within 14 days prior to urine collection
* Patient has chronic indwelling urinary catheter

Where it's running

  • Mayo Clinic in Rochester
    Rochester, Minnesota, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.